Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Yuan LQ et al. | 2020 | intact cell/cell culture, human nephroblastoma cell line G401, human embryonic renal epithelial cell line HEK293, human lung cancer cell line A549, human bronchial epithelial cell line BEAS-2B, human gastric cancer cell line SGC-7901, human gastric epithelial cell line GES-1, human pancreatic cancer cell line PANC-1, human pancreatic ductal epithelial cell line HPDE6-C7, wild-type (WT) mouse embryonic fibroblast (MEF) cells, NBS1-/-MEF and MDC1-/-MEF cells | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Naarala J et al. | 2017 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC), C6 cells (rat glioma cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, shielding/field deprivation | 0.2–120 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
